All Sites This Site

Find a Program

Find a Lab

Message from the Chief

David M. Jablons, M.D.

Professor & Chief,
Section of General Thoracic Surgery

Putting Drug Development In Patients' Hands

The Addario Lung Cancer Institute is building a virtual specimen bank where researchers can share patient specimens.

Make a Gift

Your gift helps scientists discover new treatments and cures for lung cancer, esophegeal cancer and mesothelioma.

Treatment Options by Stage & Recurrence


Noninvasive Thymoma and Thymic Carcinoma

Treatment of noninvasive thymoma and thymic carcinoma may include the following1:

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with noninvasive thymoma and thymic carcinoma.

Invasive Thymoma and Thymic Carcinoma

Treatment of invasive thymoma and thymic carcinoma that may be completely removed by surgery includes the following:

Treatment of invasive thymoma and thymic carcinoma that cannot be removed completely by surgery includes the following:

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with invasive thymoma and thymic carcinoma.

Recurrent Thymoma and Thymic Carcinoma

Treatment of recurrent thymoma and thymic carcinoma may include the following:

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent thymoma and thymic carcinoma.

 

 

 

 Email Page  
Send Email to *: (You can include up to four email addresses, separated by a comma)
Your Email Address *:
Email Subject *:
Comment: (maximum of 200 characters)

* required fields